Serif Health, a San Francisco-based healthcare data company focused on price transparency, has secured a significant minority investment from growth equity firm SEVA Growth LP. The transaction represents Serif’s first outside institutional capital and is intended to support the expansion of its customer base, product capabilities, and data infrastructure. Financial terms of the investment were not disclosed.
Expanding Serif’s Growth Strategy
Serif plans to use the new capital to accelerate sales and broader growth initiatives while advancing its pipeline of product features and data APIs. The company said the investment will help it expand its footprint among healthcare organizations that rely on accurate pricing information for benchmarking, network analysis, and market intelligence. SEVA made the investment through SEVA I LP.
As part of the transaction, SEVA founder and managing partner Shalin Mehta will join Serif Health’s board of directors. His appointment gives the growth equity firm a formal role in supporting the company as it enters its next stage of expansion. Serif co-founder and CEO Rafiq Ahmed said the partnership will help the company broaden both its customer reach and product portfolio.
Building a Healthcare Pricing Data Platform
Founded in 2020, Serif Health provides healthcare price transparency data and intelligence to providers, payers, employers, and third-party administrators. Its technology is designed to convert large volumes of pricing information into standardized, usable datasets that customers can analyze through its platform. The company focuses on areas including reimbursement rate searches, market benchmarking, network strategy, and competitive intelligence.
The need for such services has grown since federal transparency requirements began requiring hospitals and health insurers to publish negotiated healthcare rates. While the regulations created significantly more publicly available pricing information, inconsistencies in formatting, validation, and data quality made much of the raw information difficult for organizations to use directly. Serif addresses this problem by collecting, cleaning, validating, and standardizing pricing data from hundreds of payers, thousands of hospitals, and billions of rate records.
Growing Adoption Across Healthcare
More than 250 organizations have used Serif’s pricing data over the past three years, according to the company. Customers use the information to compare reimbursement rates, evaluate provider networks, and understand pricing dynamics across healthcare markets. Serif says its infrastructure processes and enhances hundreds of billions of healthcare reimbursement data points each month.
The company has also been expanding the capabilities of its Signal platform as healthcare organizations increasingly seek easier ways to analyze complex pricing information. Earlier in 2026, Serif introduced Signal Ask, an artificial intelligence application designed to let users explore pricing data using natural language queries. The tool allows customers to request information without needing detailed knowledge of billing codes, underlying datasets, or technical data structures.
SEVA Backs Founder-Led Technology Companies
SEVA focuses on growth investments in profitable, founder-led businesses operating across software, data, internet, marketplace, and technology-enabled services markets. Mehta said Serif has built a strong position in healthcare pricing transparency by helping customers make better-informed decisions from large and complex datasets. SEVA intends to support Ahmed and the wider Serif team as the company continues developing its platform and expanding commercially.
The investment adds Serif to a SEVA portfolio that has included companies such as Chicory, Teleskope Technologies, TitanFile, and Pronto. The firm's strategy centers on backing customer-focused technology companies with established operations and opportunities for continued expansion. Serif’s combination of healthcare data infrastructure, analytics, and emerging AI capabilities aligns with that investment approach.
SEVA’s investment gives Serif Health new capital to scale its commercial operations while continuing to develop its healthcare pricing intelligence platform. With demand for more accessible and reliable price transparency data continuing to grow, the company is positioning its Signal platform and newer AI tools as infrastructure for healthcare organizations navigating complex reimbursement markets. The transaction also marks an important financing milestone for Serif as it brings in its first institutional investor and prepares for its next phase of growth.